Atlanta Innovates with NOVABLOC™: A $10 Million Breakthrough in Postoperative Pain Relief

Atlanta’s Groundbreaking Solution to Postoperative Pain: A $10 Million Leap Forward!

In an inspiring tale of innovation and commitment, Atlanta is making waves in the medical world! A small, yet mighty team at Synaptrix, Inc. is on a noble mission to tackle one of healthcare’s toughest challenges – postoperative pain, and they’re doing it in a way that can potentially change lives.

The NOVABLOC™ System: A Game Changer in Pain Management

Founded by visionary Shyamy Sastry and his team, Synaptrix has developed an innovative device known as NOVABLOC™. This proprietary system promises to deliver pain relief for over 20 days with a single treatment, all while reducing the reliance on opioids. That’s right! No more reaching for those addictive painkillers after surgery!

Sastry described the current landscape of postoperative pain management as “largely insufficient”. Many treatments either fade too quickly, hamper recovery, or worse, lead patients down the troubling path of opioid dependency. His radical solution, NOVABLOC™, uses a technique called neuromodulation to “modify neural activity.” But don’t worry, that just means it’s a safe and effective way to send electrical stimulation right where it’s needed, suppressing the pain signals without hindering movement or sensation.

A Resounding Investment

Recently, this innovative team garnered attention—and support! They just announced a whopping $10 million in Series A funding, led by Hatteras Venture Partners based in Durham. Adding to the mix are several other prominent investors from the healthcare sector, including RexHealth Ventures and Avanos Medical. Talk about a vote of confidence in their game-changing idea!

Sastry revealed that Synaptrix sprang from the medical device giant Avanos, and it was a connection through their chairman, Bob Crutchfield, that led them to this significant investment. With these funds, the Synaptrix team is geared up to dive into pivotal studies, navigate regulatory processes, and move forward with the commercialization of their NOVABLOC™ system.

Focusing on Total Knee Arthroplasties

The initial focus for clinical studies is on patients undergoing total knee arthroplasty, a common procedure among seniors seeking relief from debilitating knee pain. The stakes couldn’t be higher. Imagine aiding recovery while providing lasting pain relief without the nasty side effects of opioids!

An Ecosystem of Innovation in Atlanta

It’s no coincidence that Synaptrix is based in Atlanta. The city is blossoming into a hub for life sciences, medical, and healthcare technology. It’s home to phenomenal institutions like the CDC, not to mention top medical schools and a leading biomedical engineering program. Atlanta is brimming with R1 research institutions like Emory and Georgia Tech, creating an ecosystem ripe for medical device innovations.

Sastry expressed confidence in Atlanta’s support, noting the close-knit community of orthopedics and engineering professionals rallying behind them. Moreover, he points out that it’s an easily accessible location for their out-of-town investors and collaborators. “We find our network in Atlanta forming very well,” he said, emphasizing how the city’s resources play a crucial role in their success.

Looking Ahead

As Synaptrix prepares to usher in a new wave of pain management solutions, they are hoping that the NOVABLOC™ system will not only enhance postoperative experiences but also set a new standard in the fight against opioid addiction.

In a world where pain relief often comes at a price, both financially and health-wise, the advent of SYNAPTRIX and NOVABLOC™ is a refreshing breath of fresh air. With Atlanta at the forefront of this transformation, it’s exciting to think about what the future holds for pain management technology!